What histochemical stains can distinguish seminoma from embryonal carcinoma, choriocarcinoma, and granulosa cell tumor?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Histochemical stains such as OCT4, CD30, and SALL4 can be used to distinguish between seminoma, embryonal carcinoma, and other germ cell tumors, while inhibin, calretinin, and FOXL2 are useful for identifying granulosa cell tumors. The most recent and highest quality study 1 provides a comprehensive overview of the immunohistochemical markers used in the diagnosis of germ cell tumors and sex cord-stromal tumors.

Key Findings

  • Seminoma can be identified by positive staining for OCT4 and SALL4, while embryonal carcinoma shows positive staining for CD30, OCT4, and SALL4.
  • Choriocarcinoma can be identified by positive staining for human chorionic gonadotropin (hCG) and cytokeratins.
  • Granulosa cell tumors demonstrate positive staining for inhibin, calretinin, and FOXL2, while being negative for PLAP and CD30.

Diagnostic Approach

  • A combination of histological examination and immunohistochemical staining is essential for accurate diagnosis.
  • The use of a panel of immunohistochemical markers, including OCT4, CD30, SALL4, inhibin, calretinin, and FOXL2, can help distinguish between different types of germ cell tumors and sex cord-stromal tumors.
  • Expert pathological evaluation is crucial for accurate diagnosis and treatment planning, as recommended by 1.

Clinical Implications

  • Accurate diagnosis of germ cell tumors and sex cord-stromal tumors is critical for determining prognosis and guiding treatment.
  • The use of immunohistochemical stains can help identify specific tumor types and inform treatment decisions, as discussed in 1 and 1.
  • A multidisciplinary approach, including expert pathological evaluation and clinical correlation, is essential for optimal patient care.

From the Research

Histochemical Stains for Testicular Tumors

To distinguish between seminoma, embryonal carcinoma, choriocarcinoma, and granulosa cell tumor, several histochemical stains can be used:

  • OCT4: Expressed in seminoma and embryonal carcinoma, making it a useful marker for these tumors 2
  • D2-40: Positive in seminoma, but also shows focal positivity in some embryonal carcinomas, limiting its utility in distinguishing between these two tumors 3
  • CD30: Expressed in embryonal carcinoma, but can also be found focally in seminoma, particularly in mixed tumors 4, 5
  • CD117 (c-kit): Regularly expressed in seminoma, but not in embryonal carcinoma, making it a useful marker in combination with CD30 for distinguishing between these two tumors 5
  • Cytokeratin 7 (CK7), inhibin, and p63: Useful markers for choriocarcinoma, with CK7 being highly sensitive and inhibin and p63 being sensitive and specific for choriocarcinoma versus seminoma, embryonal carcinoma, and yolk sac tumor 6
  • β-human chorionic gonadotropin (β-hCG): Can be used to identify choriocarcinoma, but is not as specific as CK7, inhibin, and p63, as it can also be expressed in other tumor types 6

Specific Stains for Each Tumor Type

  • Seminoma: OCT4, D2-40, CD117 (c-kit)
  • Embryonal carcinoma: OCT4, CD30
  • Choriocarcinoma: CK7, inhibin, p63, β-hCG
  • Granulosa cell tumor: No specific stains mentioned in the provided studies, but inhibin can be used to identify sex-cord stromal tumors, which include granulosa cell tumors 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

D2-40 immunohistochemistry in the differential diagnosis of seminoma and embryonal carcinoma: a comparative immunohistochemical study with KIT (CD117) and CD30.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2007

Research

CD30 expression in seminoma.

Human pathology, 1996

Research

CD30 and CD117 (c-kit) used in combination are useful for distinguishing embryonal carcinoma from seminoma.

The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.